
Frontiers of Cancer Biology
Current Trends in Cancer Research
- 1st Edition - December 1, 2025
- Imprint: Academic Press
- Editors: Devavarapu Kasi Viswa Prasad, Sitara Roy
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 3 3 0 2 - 6
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 3 3 0 3 - 3
Frontiers of Cancer Biology: Current Trends in Cancer Research offers a comprehensive introduction to the genetic factors of cancer, detailing the roles of genomic instab… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteAdditionally, it addresses the latest trends and future directions in cancer genetics, making it an invaluable resource for researchers, professionals in the field, and academics looking to stay updated with cutting-edge developments in cancer biology.
- Provides a comprehensive overview of cancers
- Explores clinical relevance of cancer in relation to genetics
- Reviews emerging trends and therapeutic targets in cancer, as well as the future of cancer genetics
2. Role of Genomic Instability and Gene Mutations in Carcinogenesis and Metastasis
3. Role of Oncogenes, Proto-oncogenes, and Tumor Suppressor Genes in Cancer Progression
4. The Role of DNA Damage and Repair in Cancer Pathogenesis
5. Viral genomics and cancer
6. Epigenetics and Cancer
7. Cancer Genetics, Chemotherapy and advance therapy
8. Childhood cancer genomics
9. Role of gene therapy and immunotherapy in precision medicine
10. Genetic testing, genetic counseling, and cancer risk assessment during cancer therapy
11. Future directions and progress in cancer genetics
- Edition: 1
- Published: December 1, 2025
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9780443333026
- eBook ISBN: 9780443333033
DP
Devavarapu Kasi Viswa Prasad
Dr. Devavarapu Kasi Viswa Prasad is an Associate Professor in Department of Biochemistry and In-charge Central Diagnostic Laboratory, GITAM Institute of Medical Sciences & Research at Visakhapatnam, Andhra Pradesh. Dr. Prasad obtained his medical degree from Nagarjuna University, Andhra Pradesh., M.Sc. (Psychology) from Madras University., M.Sc. (Medical Biochemistry) and Ph.D. (Medical Biochemistry) from Dr. N.T.R. University of Health Sciences, Vijayawada, Andhra Pradesh. He has more than 25 years of teaching experience in Biochemistry and also mentored Post graduate medical biochemistry students to his credit. His research focused on genetics of idiopathic generalized epilepsy (IGE) and its association with oxidative stress and antiepileptic drug therapy. He successfully published his work in national and internationally reputed journals. He co-authored nearly 15 book chapters in different books. He also presented abstracts at various national and international conferences. Dr. Prasad has completed the clinical biochemistry degree MIBCB (Member of Indian Board of Clinical Biochemistry), which is empanelled by Quality Council of India (QCI). He is a member of many international scientific societies and organizations. He is a member secretary for Institutional Ethics Committee, NRI Institute of Medical Sciences, Visakhapatnam. He is a reviewer of several international journals and serves as editorial board member for well reputed international and national journals.
SR
Sitara Roy
With over 12 years of dedicated research experience in Human Genetics, encompassing roles at esteemed institutions such as Harvard and UCSD, I've nurtured an in-depth grasp of the field. Dr Sitara Roy’s accomplished portfolio features a prominent publication on gene editing spotlighted in Science Advances. He embarked on his academic journey by delving into brain stroke genetics for his PhD, transitioning subsequently to cancer biology during his postdoctoral tenure at TIFR. This dynamic trajectory uniquely equips him to address the intricate realm of cancer in a comprehensive manner. Dr Roy’s expertise spans diverse research domains, ranging from genetic fundamentals to innovative gene editing methodologies. Currently at Harvard, he is engaged in unraveling gene function, expression, and manipulation to enhance our comprehension of gene regulation. This rich background positions him aptly to authoritatively craft a transformative book that enriches the field of cancer research.